Pharmafile Logo

Patients and data tracking

- PMLiVE

Four more coronavirus cases confirmed in the UK

Secretary of State declares outbreak a “serious and imminent threat”

- PMLiVE

Skyrizi, Rinvoq help AbbVie weather Humira slowdown

The company expects overall earnings growth to be around 8% this year

- PMLiVE

Double blow to amyloid drug hopes as Roche, Lilly trial fails

The two investigational candidates were unable to show benefit

- PMLiVE

CRISPR gene-editing in cancer patients is safe, according to new study

Patients had no side effects following CRISPR treatment

- PMLiVE

Prime Global launches new market access consultancy

Prime Access Consultancy will build on agency’s existing expertise

- PMLiVE

Genactis, emotive and Initiate join forces to create Synaptic Health

New collective of agencies and consultancies has launched

- PMLiVE

Celgene drugs drive BMS to a buoyant Q4, but Opdivo stalls

BMS share price up by 3% on the back of results

- PMLiVE

Biogen triumphs over Mylan’s Tecfidera patent challenge

Shares in Biogen skyrocketed by 32% following ruling

- PMLiVE

Chiesi launches new rare disease R&D division

New business unit will be based in Boston, US

- PMLiVE

GSK considers more divestments to help R&D push

Turns priority to future growth drivers and R&D investment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links